Profound Medical was pleased to host its second ‘PRO-Talk Live!’ event in Las Vegas this past Saturday, September 14, 2024. With 70 physicians participating, 31 of whom being existing TULSA-PRO users and the other 39 being potential users, the program featured presentations on TULSA-PRO and its unrivalled flexibility to treat a wide variety of prostate disease patients from key opinion leaders who have gained first-hand experience with the technology. In addition, members of Profound’s management team provided clinical, technology and commercial updates, with a focus on the future of TULSA-PRO. Finally, participants heard from representatives of two leading global medical technology companies, Siemens Healthineers and Cook Medical, who discussed their shared common vision with Profound of creating a total magnetic resonance solution to support the Modern Treatment Pathway that allows for more accurate and precise prostate disease diagnosis, the TULSA Procedure, and follow-up.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROF:
- Profound Medical to Attend Growth Ideas Conference
- Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
- Profound Medical management to meet virtually with Lake Street
- Profound Medical Sees Strong Revenue Growth in Q2
- Profound Medical backs FY24 revenue view $11M-$12M, consensus $11.27M
Questions or Comments about the article? Write to editor@tipranks.com